Pembrolizumab vs Tamoxifen

## Pembrolizumab vs Tamoxifen: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Tamoxifen**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Tamoxifen**: Selective estrogen receptor modulator (SERM).

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Tamoxifen — 5-7 days.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Tamoxifen — C26H29NO.

**Molecular Weight**: Pembrolizumab — N/A; Tamoxifen — 371.5150 g/mol.

**Type**: Pembrolizumab — Antibody; Tamoxifen — Small molecule.